Marché mondial des tests de dépistage des maladies sexuellement transmissibles (MST) – Tendances et prévisions du secteur jusqu’en 2029

Analyse du marché et perspectives du marché des tests de maladies sexuellement transmissibles (MST)

Selon les analyses de Data Bridge Market Research, le marché des tests de maladies sexuellement transmissibles (MST) devrait représenter 1 58 734,55 millions USD d'ici 2029, avec un TCAC de 7,85 % au cours de la période de prévision 2022-2029. L'augmentation des cas de gonorrhée et de chlamydia et la sensibilisation croissante du public aux maladies sexuellement transmissibles sont les facteurs qui créeront de nouvelles opportunités pour le marché des tests de maladies sexuellement transmissibles au cours de la période de prévision.

Les maladies sexuellement transmissibles sont celles qui se transmettent par contact sexuel. Elles peuvent également se transmettre par l'allaitement, l'accouchement et, dans certains cas, par le partage d'aiguilles.

Les facteurs importants qui stimulent la croissance du marché des tests de maladies sexuellement transmissibles (MST) comprennent une sensibilisation accrue du public et l'éducation des patients. En outre, l'augmentation de la prévalence des maladies sexuellement transmissibles à l'échelle mondiale, la sensibilisation accrue des patients grâce à des campagnes d'éducation et une augmentation des initiatives gouvernementales devraient stimuler la croissance du marché. Au cours de la dernière décennie, on a constaté une augmentation significative de la prévalence et de l'incidence des maladies sexuellement transmissibles. À mesure que la prévalence des maladies sexuellement transmissibles augmente, les pays du monde entier se concentrent sur la mise en œuvre de programmes nationaux de dépistage pour augmenter la couverture du diagnostic des maladies sexuellement transmissibles. En outre, les politiques de remboursement des services de maladies sexuellement transmissibles ont été favorables. Ces facteurs stimulent considérablement la croissance du marché mondial des tests de maladies sexuellement transmissibles.

Les progrès technologiques et les avancées dans le diagnostic des maladies sexuellement transmissibles devraient également stimuler la croissance du marché. La mise en œuvre accrue de programmes nationaux de dépistage pour améliorer la couverture du diagnostic des maladies sexuellement transmissibles élargira également le marché des tests de maladies sexuellement transmissibles.

Lack of patient awareness is likely to hamper the growth of the sexually transmitted diseases (STD) testing market during the forecast period. The side effects of these medications are less severe than those of other treatments. Infection, on the other hand, is a serious constraint. Overdoes of analgesic post-operative pain medication, in particular, are causing a high death rate. These medications are not appropriate for the majority of patients. These factors are limiting the decline and patient interest in these devices.

This sexually transmitted diseases (STD) testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sexually transmitted diseases (STD) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sexually Transmitted Diseases (STD) Testing Market Scope and Market Size

STD testing market is segmented of the basis of disease type and location of testing. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of disease type, the sexually transmitted diseases (STD) testing market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, and other.
• The sexually transmitted diseases (STD) testing market is also segmented on the basis of location of testing. The location of testing segment is further divided into laboratory testing and point of care (POC) testing.

.Sexually Transmitted Diseases (STD) Testing Market Country Level Analysis

The sexually transmitted diseases (STD) testing market is analysed and market size insights and trends are provided by country, disease type and location of testing as referenced above.

The countries covered in the sexually transmitted diseases (STD) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominated the market accounting for the largest share, and this trend is expected to continue throughout the forecast period. This is due to an increase in the number of cases of sexually transmitted diseases in developing countries. Furthermore, increased patient awareness through education campaigns and expanding government initiatives are expected to drive the sexually transmitted diseases testing market growth.

The country section of the sexually transmitted diseases (STD) testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The sexually transmitted diseases (STD) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sexually transmitted diseases (STD) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sexually transmitted diseases (STD) testing market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Sexually Transmitted Diseases (STD) Testing Market Share Analysis

Le paysage concurrentiel du marché des tests de maladies sexuellement transmissibles (MST) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des tests de maladies sexuellement transmissibles (MST).

Français Certains des principaux acteurs opérant sur le marché des tests de maladies sexuellement transmissibles (MST) sont bioMérieux SA, BD, Hologic, Inc., OraSure Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott. Merck & Co. Inc., Johnson & Johnson Services, Inc, GlaxoSmithKline Plc., Allergen, Bayer AG, Bristol-Myers Squibb Company, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Sorrento Therapeutics, Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, Inc., Medtronic, Boston Scientific Corporation, Halyard Health, Inc. et Neurotech Na, Inc. entre autres.

SKU-24256